CN104523341B - The manufacture method of the immediate implantation teeth with periodontal bioactivity - Google Patents
The manufacture method of the immediate implantation teeth with periodontal bioactivity Download PDFInfo
- Publication number
- CN104523341B CN104523341B CN201410781591.0A CN201410781591A CN104523341B CN 104523341 B CN104523341 B CN 104523341B CN 201410781591 A CN201410781591 A CN 201410781591A CN 104523341 B CN104523341 B CN 104523341B
- Authority
- CN
- China
- Prior art keywords
- gln
- phe
- pro
- root
- bioactivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 230000003239 periodontal effect Effects 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 238000002513 implantation Methods 0.000 title claims description 16
- 239000007943 implant Substances 0.000 claims abstract description 36
- 229920001436 collagen Polymers 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 29
- 108010035532 Collagen Proteins 0.000 claims abstract description 29
- KMQAPZBMEMMKSS-UHFFFAOYSA-K calcium;magnesium;phosphate Chemical compound [Mg+2].[Ca+2].[O-]P([O-])([O-])=O KMQAPZBMEMMKSS-UHFFFAOYSA-K 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 16
- 230000000975 bioactive effect Effects 0.000 claims abstract description 15
- 239000011159 matrix material Substances 0.000 claims abstract description 11
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000010936 titanium Substances 0.000 claims abstract description 9
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 9
- 229910001069 Ti alloy Inorganic materials 0.000 claims abstract description 6
- 239000011248 coating agent Substances 0.000 claims abstract description 3
- 238000000576 coating method Methods 0.000 claims abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 239000011777 magnesium Substances 0.000 claims description 13
- 239000011575 calcium Substances 0.000 claims description 12
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000004570 mortar (masonry) Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 238000013019 agitation Methods 0.000 claims 2
- UUVBYOGFRMMMQL-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca].OP(O)(O)=O UUVBYOGFRMMMQL-UHFFFAOYSA-N 0.000 claims 2
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 claims 2
- 229910000071 diazene Inorganic materials 0.000 claims 2
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 2
- -1 aminopropyl Chemical group 0.000 claims 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 238000009777 vacuum freeze-drying Methods 0.000 claims 1
- 102400000096 Substance P Human genes 0.000 abstract description 26
- 101800003906 Substance P Proteins 0.000 abstract description 26
- 239000004053 dental implant Substances 0.000 abstract description 20
- 230000004071 biological effect Effects 0.000 abstract description 10
- 238000000605 extraction Methods 0.000 abstract description 10
- 230000035876 healing Effects 0.000 abstract description 10
- 239000011664 nicotinic acid Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000004108 freeze drying Methods 0.000 abstract description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 18
- 210000000988 bone and bone Anatomy 0.000 description 15
- 230000000694 effects Effects 0.000 description 10
- 239000001506 calcium phosphate Substances 0.000 description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 description 8
- 235000011010 calcium phosphates Nutrition 0.000 description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000010478 bone regeneration Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 5
- 239000012154 double-distilled water Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000010883 osseointegration Methods 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- QHXGAGNEAXASFC-UHFFFAOYSA-N 3-(ethyliminomethylideneamino)-1-n,1-n'-dimethylpropane-1,1-diamine Chemical compound CCN=C=NCCC(NC)NC QHXGAGNEAXASFC-UHFFFAOYSA-N 0.000 description 4
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 210000003556 vascular endothelial cell Anatomy 0.000 description 3
- 208000006386 Bone Resorption Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 229910019440 Mg(OH) Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000024279 bone resorption Effects 0.000 description 2
- 230000008416 bone turnover Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 2
- 230000001483 mobilizing effect Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000005245 sintering Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000000332 tooth crown Anatomy 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000037408 Device failure Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 206010041290 Soft tissue inflammation Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 201000005562 gingival recession Diseases 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 208000004480 periapical periodontitis Diseases 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000006032 tissue transformation Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明涉及具有牙周生物活性的即刻种植牙的制造方法,包括如下步骤:(1)制备纯钛或钛合金种植体芯;(2)制备自固化磷酸钙镁粉剂;(3)制备胶原溶液;(4)制备人工合成P物质多肽;(5)制备SP交联胶原基质;(6)磷酸钙镁粉剂与SP交联胶原基质混合调拌制备生物活性糊剂;(7)生物活性糊剂包被种植体芯的根部并加压固化和冻干制成具有牙周生物活性的人工牙根;(8)种植体芯的冠部连接适合缺牙外形的人工牙冠制成即刻种植牙。该方法通过构建仿生牙骨质结构人工牙根,从而使得制备的种植牙具备天然移植牙的部分生命特征,具有自主牙周愈合生物活性,可以在拔牙后即刻种植,显著缩短缺牙修复时间,提高种植成功率。
The invention relates to a manufacturing method of an immediate dental implant with periodontal bioactivity, comprising the following steps: (1) preparing a pure titanium or titanium alloy implant core; (2) preparing a self-curing calcium magnesium phosphate powder; (3) preparing a collagen solution (4) Preparation of artificially synthesized substance P polypeptide; (5) Preparation of SP cross-linked collagen matrix; (6) Calcium magnesium phosphate powder mixed with SP cross-linked collagen matrix to prepare bioactive paste; (7) Bioactive paste Coating the root of the implant core, pressurizing, solidifying and freeze-drying to make an artificial tooth root with periodontal bioactivity; (8) connecting the crown of the implant core to an artificial crown suitable for the shape of the missing tooth to make an immediate implant. This method constructs an artificial tooth root with a bionic cementum structure, so that the prepared dental implant has part of the life characteristics of a natural implanted tooth, has the biological activity of autonomous periodontal healing, and can be implanted immediately after tooth extraction, which significantly shortens the restoration time of missing teeth and improves the quality of life. planting success rate.
Description
技术领域technical field
本发明属于牙科人工种植体技术领域,涉及一种生物活性种植牙的制造方法,尤其涉及一种可以在拔牙后即刻种植并主动诱导在种植牙的牙根与牙槽窝骨组织之间形成骨结合的种植牙制造方法。The invention belongs to the technical field of dental artificial implants, and relates to a method for manufacturing biologically active dental implants, in particular to a method that can be implanted immediately after tooth extraction and actively induces the formation of osseointegration between the root of the implant and the bone tissue of the alveolar socket dental implant manufacturing method.
背景技术Background technique
种植牙(dental implant)被称为人类的第三副牙齿,已经成为现代口腔医学的标志性技术。现代牙科种植技术的发展成熟是基于种植牙之父Branemark于上世纪60年代提出的骨结合理论(osseointegration,或称为骨整合)。美国牙科种植学会对骨结合的定义为:正常的改建骨和种植体直接接触,无光镜下可见到的软组织长入,并能使种植体的负荷持续传导并分散在骨组织中。Dental implant (dental implant) is called the third pair of teeth of human beings and has become a symbolic technology of modern stomatology. The development of modern dental implant technology is based on the theory of osseointegration (or osseointegration) proposed by Branemark, the father of implant in the 1960s. The American Academy of Dental Implantology defines osseointegration as: normal remodeled bone is in direct contact with the implant, soft tissue can be seen under a light-free microscope, and the load of the implant can be continuously conducted and dispersed in the bone tissue.
现代牙种植体主要采用钛金属或陶瓷等无机材料通过机械加工制成,材料表面具有较好的生物相容性,但难以构建持续稳定的再生诱导生物活性,所以种植体植入后的顺利愈合需要良好的初期稳定性,即,植入时种植体就能与周围牙槽骨形成足够面积的直接接触。为此,传统种植手术一般安排在拔牙后3-6个月牙槽窝骨组织再生愈合良好时进行,并且植入后需要包埋或静止愈合3个月,以获得良好的种植体骨结合,再行二次手术。连接上部义齿结构。Modern dental implants are mainly made of inorganic materials such as titanium metal or ceramics through mechanical processing. The surface of the material has good biocompatibility, but it is difficult to build a sustainable and stable regeneration-induced biological activity, so the smooth healing of the implant after implantation Good primary stability is required, that is, the implant can form a sufficient area of direct contact with the surrounding alveolar bone when placed. For this reason, traditional implant surgery is generally scheduled for 3-6 months after tooth extraction when the alveolar bone tissue regeneration and healing are good, and after implantation, embedding or static healing is required for 3 months to obtain good implant osseointegration. A second operation was performed. Connects to the upper denture structure.
即刻种植,是在拔牙同时将种植牙植入牙槽窝,待其愈合后即可连接义齿修复缺牙,从而减少手术次数和手术创伤,早期恢复牙齿咬合和美学功能,是口腔重建技术发展的重要方向。近年研究表明拔牙后即刻种植也可以实现骨结合愈合,但是,新鲜牙槽窝的形态与种植体难以完全匹配,并且牙槽骨可能因牙周和根尖疾病等受损,因而即刻种植常常难以获得必要的初期稳定性和良好的愈合环境,其近远期功能和美学效果仍有较多争论。目前即刻种植适用位点一般为前牙及前磨牙,要求根方至少有3-5mm以上骨量,以稳定植入种植体,而磨牙位点拔牙后牙槽窝宽大,牙槽中隔骨量多难以支持种植体稳定性,所以临床很少采用即刻种植,一般在拔牙4个月后待牙槽窝完全骨性愈合时种植。如果患牙位点因牙周疾患和/或根尖周炎存在大量骨缺损和/或软组织炎症,或患者有骨质疏松、糖尿病等全身系统性疾病,也不是即刻种植的适应证。另外,前牙区唇颊侧牙槽骨壁主要由薄弱的皮质骨组成,牙齿拔除后会随之发生生理性吸收,现有种植体并不能阻止这种骨吸收,可能导致牙龈退缩和种植体边缘暴露,严重影响美学效果。综上所述,目前的种植体设计用于即刻种植时,需要更为严格的适应证选择,而且一般需要更为复杂的材料和技术辅助,临床应用受到较多限制。Immediate implant is to implant the implant into the alveolar socket at the same time as the tooth is extracted. After it heals, the denture can be connected to repair the missing tooth, thereby reducing the number of operations and surgical trauma, and restoring the occlusal and aesthetic functions of the teeth early. It is the development of oral reconstruction technology. important direction. Recent studies have shown that immediate implantation after tooth extraction can also achieve osseointegrated healing. However, it is difficult to completely match the shape of the fresh alveolar socket with the implant, and the alveolar bone may be damaged due to periodontal and apical diseases, so immediate implantation is often difficult to obtain the necessary Its initial stability and good healing environment, its short-term and long-term functional and aesthetic effects are still controversial. At present, the suitable sites for immediate implantation are generally anterior teeth and premolars, which require at least 3-5mm of bone mass at the root to stably implant the implant, while the alveolar sockets of the molar sites are wide after tooth extraction, and the interalveolar bone mass It is difficult to support the stability of the implant, so immediate implantation is rarely used clinically, and it is generally implanted when the alveolar socket is completely healed 4 months after tooth extraction. If there is a large amount of bone defect and/or soft tissue inflammation at the tooth site due to periodontal disease and/or apical periodontitis, or the patient has systemic diseases such as osteoporosis and diabetes, it is not an indication for immediate implantation. In addition, the alveolar bone wall on the labial and buccal side of the anterior teeth is mainly composed of weak cortical bone, which will undergo physiological resorption after tooth extraction. The existing implants cannot prevent this bone resorption, which may lead to gingival recession and implant failure. The edges are exposed, seriously affecting the aesthetic effect. To sum up, when the current implants are designed for immediate implantation, more stringent selection of indications is required, and generally more complex materials and technical assistance are required, and the clinical application is more limited.
利用生物活性因子加载,使种植体具备诱导骨再生重建的能力,提高即刻种植的可行性和成功率,是种植技术和理论发展的重要方向。目前常用骨再生相关生长因子或激素如BMP、甲状旁腺素等,通过各种物理或化学方法,在种植体表面构建生物活性修饰表层。但是这些生长因子为大分子蛋白,在获取合成、定位输送和活性控制等方面均存在较多问题,特别是在种植体钛金属表面,如何加载有机生物分子,如何稳定保持其生物活性,以及如何保证其生物安全性,还有较多技术瓶颈,距离牙科种植临床实际应用条件尚有较大差距。It is an important direction for the development of implant technology and theory to use bioactive factor loading to enable implants to induce bone regeneration and reconstruction, and to improve the feasibility and success rate of immediate implantation. At present, growth factors or hormones related to bone regeneration, such as BMP and parathyroid hormone, are commonly used to construct bioactive modified surfaces on the surface of implants through various physical or chemical methods. However, these growth factors are macromolecular proteins, and there are many problems in obtaining, synthesizing, positioning and transporting, and controlling their activity, especially on the surface of titanium metal implants, how to load organic biomolecules, how to maintain their biological activity stably, and how to To ensure its biological safety, there are still many technical bottlenecks, and there is still a big gap from the actual clinical application conditions of dental implants.
发明内容Contents of the invention
本发明的目的是提供一种具有牙周生物活性的即刻种植牙的制造方法,通过该方法制备的种植牙具有仿生天然牙牙根牙骨质结构的人工牙根,具备自主诱导骨再生改建能力,可于拔牙后即刻种植,模拟天然移植牙牙周愈合过程,解决缺牙早期修复重建的问题。The purpose of the present invention is to provide a method for manufacturing immediate dental implants with periodontal bioactivity. The dental implant prepared by this method has an artificial tooth root with a bionic natural tooth root cementum structure, and has the ability to independently induce bone regeneration and reconstruction. Immediate implantation after tooth extraction simulates the periodontal healing process of natural transplanted teeth and solves the problem of early restoration and reconstruction of missing teeth.
为了达到上述目的,本发明提供如下技术方案:一种具有牙周生物活性的即刻种植牙的制造方法,其包括以下步骤:(1)制备纯钛或钛合金种植体芯,其中,所述种植体芯包括冠部和根部,所述冠部中有螺孔,用于固定人工牙冠,所述根部的外表面有螺纹,用于分散咬合应力;(2)制备自固化磷酸钙镁粉剂,具体方法为:按照Mg∶Ca=3∶1的摩尔比,将Mg(OH)2与CaCO3混合,MgHPO4·3H2O与CaHPO4混合,再将两种混合物按照1∶2的摩尔比混合,然后再将混合后的物质在1100摄氏度下烧结5小时,制备磷酸钙镁材料Mg2.25Ca0.75(PO4)2;通过研钵破碎所得磷酸钙镁烧材料Mg2.25Ca0.75(PO4)2,然后再用355μm孔径筛进行筛分,筛分之后再用球磨机研磨10分钟制成粉末,并将所述粉末按照1∶1的摩尔比与Ca(H2PO4)2·H2O混合搅拌30秒,制成自固化磷酸钙镁粉剂;(3)制备胶原溶液,具体方法为:将I型胶原蛋白纤维按照质量体积浓度为3%W/V加入5mol/L的乙酸溶液中,并在4℃温度下磁力搅拌溶解,然后将溶液用半透膜双蒸水透析48小时去除乙酸成分,制成胶原溶液;(4)制备人工合成P物质多肽,具体方法为:使用自动多肽合成仪按照以下氨基酸序列Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2人工合成P物质多肽;(5)制备P物质共价交联改性胶原基质,具体方法为:以1-乙基-(3,3′-二甲基氨基丙基)碳酰二亚胺和N-羟基琥珀酰亚胺为共价交联剂,将所述P物质多肽、1-乙基-(3,3′-二甲基氨基丙基)碳酰二亚胺和N-羟基琥珀酰亚胺按照摩尔比1∶1.2∶0.6混合,然后将混合物按照质量体积浓度为1%W/V加入所述胶原溶液中,先磁力搅拌反应24小时,然后半透膜双蒸水透析72小时制成P物质共价交联改性胶原基质;(6)将所述自固化磷酸钙镁粉剂与0.5mol/L的枸橼酸溶液按照质量体积比例为3.0g∶1ml调拌混合制成自固化磷酸钙镁糊剂,再以体积比例60%∶40%将所述自固化磷酸钙镁糊剂与所述P物质共价交联改性胶原基质调拌混合制成生物活性糊剂;(7)制备两段式生物活性糊剂加压固化模具,上段用于容纳和固定所述冠部(1),下段用于容纳所述根部(2)以及所述生物活性糊剂,使所述根部(2)的表面有3mm厚度的生物活性糊剂包被,然后将所述两段式生物活性糊剂加压固话模具拼合在一起并加压至200-300kPa,置于100%湿度环境24小时使所述磷酸钙镁糊剂固化,再于-80℃冷冻12小时,真空冷冻干燥48小时,使磷酸钙镁结晶中的胶原成分固化成立体纤维网络状结构,制成具有仿生天然牙牙根牙骨质结构的人工牙根;(8)制备人工牙冠(8),使其形态与缺牙形态相似,通过螺钉(7)固定于所述冠部(1),即可制成即刻种植牙。In order to achieve the above object, the present invention provides the following technical solution: a method for manufacturing an immediate dental implant with periodontal bioactivity, which includes the following steps: (1) preparing a pure titanium or titanium alloy implant core, wherein the implant Body core comprises crown and root, and screw hole is arranged in described crown, is used for fixing artificial tooth crown, and the outer surface of described root has screw thread, is used for dispersing occlusal stress; (2) prepares self-curing calcium magnesium phosphate powder, The specific method is: according to the molar ratio of Mg:Ca=3:1, Mg(OH) 2 is mixed with CaCO 3 , MgHPO 4 3H 2 O is mixed with CaHPO 4 , and then the two mixtures are mixed according to the molar ratio of 1:2 Mixing, and then sintering the mixed material at 1100 degrees Celsius for 5 hours to prepare the calcium magnesium phosphate material Mg 2.25 Ca 0.75 (PO 4 ) 2 ; the obtained calcium phosphate magnesium sintered material Mg 2.25 Ca 0.75 (PO 4 ) was crushed by a mortar 2 , and then sieved with a 355 μm aperture sieve, and then ground with a ball mill for 10 minutes to make a powder, and the powder was mixed with Ca(H 2 PO 4 ) 2 ·H 2 O at a molar ratio of 1:1 Mix and stir for 30 seconds to make self-curing calcium magnesium phosphate powder; (3) prepare collagen solution, the specific method is: adding type I collagen fibers into 5mol/L acetic acid solution according to the mass volume concentration of 3% W/V, Dissolve under magnetic stirring at a temperature of 4°C, and then dialyze the solution with semi-permeable double-distilled water for 48 hours to remove the acetic acid component to make a collagen solution; (4) prepare artificially synthesized substance P polypeptides, the specific method is: use automatic peptide synthesis According to the following amino acid sequence Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 artificially synthesized substance P polypeptide; (5) preparing substance P covalently cross-linked modified collagen matrix, specifically The method is as follows: using 1-ethyl-(3,3′-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide as covalent cross-linking agents, the substance P polypeptide, 1 -Ethyl-(3,3'-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide are mixed according to the molar ratio of 1:1.2:0.6, and then the mixture is 1% according to the mass volume concentration W/V is added in the collagen solution, first magnetically stirred and reacted for 24 hours, then semi-permeable membrane double distilled water dialysis for 72 hours to make P substance covalently cross-linked modified collagen matrix; (6) the self-curing calcium phosphate The citric acid solution of magnesium powder and 0.5mol/L is 3.0g: 1ml according to the mass volume ratio and mixes and mixes to make self-curing calcium magnesium phosphate paste, then with volume ratio 60%: 40% the described self-curing calcium phosphate The magnesium paste is mixed with the covalently cross-linked modified collagen matrix of the P substance to make a bioactive paste; (7) prepare a two-stage bioactive paste pressurized curing mold, the upper section is used to accommodate and fix the The crown (1), the lower section is used to accommodate the root (2) and the bioactive paste, so that the root The surface of (2) is coated with a bioactive paste with a thickness of 3mm, and then the two-stage bioactive paste pressurized solidification mold is put together and pressurized to 200-300kPa, and placed in a 100% humidity environment 24 The calcium magnesium phosphate paste was solidified within 1 hour, then frozen at -80°C for 12 hours, and vacuum freeze-dried for 48 hours, so that the collagen components in the calcium magnesium phosphate crystals were solidified into a three-dimensional fiber network structure, and a bionic natural tooth root was made. The artificial tooth root of cementum structure; (8) prepare the artificial tooth crown (8), make its shape similar to the shape of the missing tooth, and fix it on the crown (1) by screws (7), you can make immediate dental implant .
进一步地,其中,所述冠部和所述根部的连接部有0.8-1mm的台阶。Further, wherein, the connection between the crown and the root has a step of 0.8-1 mm.
更进一步地,其中,最终在所述根部的外表面形成3mm厚的生物活性层。Furthermore, wherein, a bioactive layer with a thickness of 3 mm is finally formed on the outer surface of the root.
本发明的优越性在于:采用纯钛或钛合金制备牙种植体芯,具备良好的生物相容性、机械加工性能、机械力学性质,可以为即刻种植牙提供类似天然牙的整体强度;冠部可根据缺牙部位采用螺丝连接相应形态的人工牙冠,适于不同部位的缺牙修复;牙根部分包被磷酸钙镁-胶原复合生物活性材料,此复合生物活性材料以磷酸钙为基础,通过热化学反应将钙离子部分置换为镁离子,获得强化的机械力学性质和改善的骨组织引导活性,通过调制混合P物质(SP)共价交联改性胶原,获得持续稳定的多肽动员干细胞生物活性,通过加压自固化和冷冻干燥处理,获得模拟天然牙牙根牙骨质的结构和功能,制成仿生人工牙根。该种植牙可以在拔牙后即刻种植,具有自主诱导牙槽骨再生改建的牙周生物活性,能够显著缩短缺牙修复时间,提高成功率。The advantage of the present invention is that: the dental implant core is prepared by pure titanium or titanium alloy, which has good biocompatibility, machining performance, and mechanical properties, and can provide the overall strength similar to natural teeth for immediate implants; the crown According to the position of the missing tooth, screws can be used to connect the artificial crown of the corresponding shape, which is suitable for the restoration of missing teeth in different parts; the root part is coated with calcium magnesium phosphate-collagen composite bioactive material, which is based on calcium phosphate, through The thermochemical reaction partially replaces calcium ions with magnesium ions to obtain enhanced mechanical properties and improved bone tissue guidance activity. By modulating and mixing Substance P (SP) to covalently cross-link modified collagen, a sustained and stable peptide mobilization stem cell biology is obtained. Activity, through pressurized self-curing and freeze-drying, the structure and function of the natural tooth root cementum can be simulated, and the bionic artificial tooth root can be made. The dental implant can be implanted immediately after tooth extraction, has the periodontal biological activity of autonomously inducing alveolar bone regeneration and reconstruction, can significantly shorten the restoration time of missing teeth, and improve the success rate.
附图说明Description of drawings
图1是采用本发明的方法制造的具有牙周生物活性的即刻种植牙的放大图。Fig. 1 is an enlarged view of an immediate implant with periodontal bioactivity manufactured by the method of the present invention.
具体实施方式detailed description
下面结合附图详细描述本发明的具体实施方式,具体实施方式的内容不作为对本发明的保护范围的限制。The specific embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings, and the content of the specific embodiments is not intended to limit the protection scope of the present invention.
本发明所述的具有牙周生物活性的即刻种植牙的制造方法利用材料学与组织工程学技术相结合的非涂层生物改性技术,构建仿生牙骨质结构人工牙根,从而使得制备的种植牙可以在拔牙后即刻种植,具备天然移植牙的部分生命特征,极大缩短缺牙修复时间,显著提高种植成功率。The manufacturing method of the immediate implant with periodontal bioactivity according to the present invention utilizes the non-coating biological modification technology combining material science and tissue engineering technology to construct the artificial tooth root with bionic cementum structure, so that the prepared implant The tooth can be implanted immediately after tooth extraction, which has some life characteristics of natural implanted teeth, greatly shortens the restoration time of missing teeth, and significantly improves the success rate of implantation.
本发明的构思是利用小分子肽段构建生物活性,利用自固化磷酸钙材料构建天然牙牙骨质仿生结构。小分子活性肽在合成保存、功能定位和安全控制等方面具有显著优势,是构建组织工程生物活性的更好选择。研究表明,十一肽P物质(Substance P,SP)广泛分布于骨髓基质细胞、血管内皮细胞、中性粒细胞、上皮细胞等,具有高度保守性,是动员干细胞活化和分化的神经内分泌信号,具有诱导血管新生、促进骨再生和骨转换等多种功能作用,是一种方便易得、作用多样、安全可靠的小分子活性肽。而自固化磷酸钙在构建复合生物材料方面,具有独特的优势:磷酸钙本身具有骨组织引导活性,能够从可随意塑形的糊剂状态自固化为具有良好强度的羟磷灰石结晶状态,能够通过离子置换等方法控制固化强度,固化反应温和,能够通过物理吸附、共价交联等多种方式加载生物活性成分,实现骨引导+骨诱导多重生物活性。The idea of the present invention is to use small molecule peptides to build biological activity, and use self-curing calcium phosphate materials to build natural cementum biomimetic structures. Small molecule active peptides have significant advantages in synthesis preservation, functional positioning and safety control, and are a better choice for constructing tissue engineering biological activity. Studies have shown that Substance P (Substance P, SP) is widely distributed in bone marrow stromal cells, vascular endothelial cells, neutrophils, epithelial cells, etc., and is highly conserved. It is a neuroendocrine signal to mobilize stem cell activation and differentiation. It has various functions such as inducing angiogenesis, promoting bone regeneration and bone turnover, and is a convenient, easy-to-obtain, diverse, safe and reliable small molecule active peptide. Self-curing calcium phosphate has unique advantages in the construction of composite biomaterials: calcium phosphate itself has bone tissue guiding activity, and can self-cure from a paste state that can be shaped at will to a hydroxyapatite crystal state with good strength. The curing strength can be controlled by ion exchange and other methods, and the curing reaction is mild. Bioactive ingredients can be loaded by physical adsorption, covalent cross-linking and other methods to achieve multiple biological activities of bone conduction + bone induction.
在本发明中,首先利用高精度车床制备纯钛或钛合金牙种植体芯。如图1所示,所述纯钛或钛合金种植体芯包括冠部1和根部2,且所述冠部1和所述根部2的连接部有0.8-1mm的台阶3。所述冠部1的中心具有螺纹孔4,通过插入所述螺纹孔4的螺钉7可以固定人工牙冠8。所述根部2的外表面具有螺纹5,通过所述螺纹5分散咬合应力。In the present invention, a high-precision lathe is first used to prepare a pure titanium or titanium alloy dental implant core. As shown in FIG. 1 , the pure titanium or titanium alloy implant core includes a crown 1 and a root 2 , and the connection between the crown 1 and the root 2 has a step 3 of 0.8-1 mm. The center of the crown 1 has a threaded hole 4 through which a screw 7 inserted into the threaded hole 4 can fix an artificial dental crown 8 . The outer surface of the root 2 has threads 5 through which the occlusal stress is dispersed.
第二步,制备自固化磷酸钙镁粉剂。具体方法为:按照Mg∶Ca=3∶1的摩尔比,将Mg(OH)2与CaCO3混合,MgHPO4·3H2O与CaHPO4混合,再将两种混合物按照1∶2的摩尔比混合,然后再将混合后的物质在1100摄氏度下烧结5小时,通过热化学反应以镁离子替代部分钙离子,制备磷酸钙镁材料Mg2.25Ca0.75(PO4)2。接着,通过研钵破碎所制备的磷酸钙镁材料Mg2.25Ca0.75(PO4)2,然后再用355μm孔径筛进行筛分,筛分之后再用球磨机研磨10分钟制成粉末,并将所述粉末按照1∶1的摩尔比与Ca(H2PO4)2·H2O混合搅拌30秒,制成自固化磷酸钙镁粉剂。The second step is to prepare self-curing calcium magnesium phosphate powder. The specific method is: according to the molar ratio of Mg:Ca=3:1, Mg(OH) 2 is mixed with CaCO 3 , MgHPO 4 3H 2 O is mixed with CaHPO 4 , and then the two mixtures are mixed according to the molar ratio of 1:2 mixing, and then sintering the mixed material at 1100 degrees Celsius for 5 hours, replacing part of the calcium ions with magnesium ions through a thermochemical reaction to prepare a calcium magnesium phosphate material Mg 2.25 Ca 0.75 (PO 4 ) 2 . Next, the prepared calcium magnesium phosphate material Mg 2.25 Ca 0.75 (PO 4 ) 2 was crushed by a mortar, and then sieved with a 355 μm aperture sieve. After the sieve, it was ground with a ball mill for 10 minutes to make a powder, and the The powder is mixed with Ca(H 2 PO 4 ) 2 ·H 2 O at a molar ratio of 1:1 and stirred for 30 seconds to prepare self-curing calcium magnesium phosphate powder.
第三步,制备胶原溶液。具体方法为:将I型胶原纤维按照3%(质量体积W/V)浓度加入5mol/L的乙酸溶液,在4℃温度下磁力搅拌24小时进行充分溶解,然后将所得到的溶液半透膜双蒸水透析48小时,每6小时更换双蒸水,去除乙酸成分,制成胶原溶液。The third step is to prepare the collagen solution. The specific method is: add type I collagen fibers to 5mol/L acetic acid solution at a concentration of 3% (mass volume W/V), stir magnetically at 4°C for 24 hours to fully dissolve, and then dissolve the obtained solution into a semipermeable membrane Dialyze with double distilled water for 48 hours, replace the double distilled water every 6 hours, remove the acetic acid component, and make collagen solution.
第四步,制备人工合成P物质多肽。具体方法为:使用自动多肽合成仪按照以下氨基酸序列Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2人工合成P物质多肽。The fourth step is to prepare artificially synthesized substance P polypeptide. The specific method is: use an automatic polypeptide synthesizer to artificially synthesize the substance P polypeptide according to the following amino acid sequence Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2.
第五步,制备P物质共价交联改性胶原基质。具体方法为:以1-乙基-(3,3′-二甲基氨基丙基)碳酰二亚胺和N-羟基琥珀酰亚胺为共价交联剂,将所述P物质多肽、1-乙基-(3,3′-二甲基氨基丙基)碳酰二亚胺和N-羟基琥珀酰亚胺按照摩尔比1∶1.2∶0.6混合,然后将混合物按照质量体积浓度为1%W/V加入所述胶原溶液中,先磁力搅拌反应24小时,然后半透膜双蒸水透析72小时制成P物质共价交联改性胶原基质。The fifth step is to prepare substance P covalently cross-linked modified collagen matrix. The specific method is: using 1-ethyl-(3,3′-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide as covalent cross-linking agents, the substance P polypeptide, 1-ethyl-(3,3'-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide are mixed according to the molar ratio of 1:1.2:0.6, and then the mixture is mixed according to the mass volume concentration of 1 %W/V was added into the collagen solution, firstly reacted with magnetic stirring for 24 hours, and then the semipermeable membrane was dialyzed with double distilled water for 72 hours to prepare substance P covalently cross-linked modified collagen matrix.
第六步,将所述自固化磷酸钙镁粉剂与0.5mol/L的枸橼酸溶液按照质量体积浓度为3.0g/ml调拌混合制成自固化磷酸钙镁糊剂,再以60%∶40%体积比的比例,将所述自固化磷酸钙镁糊剂与所述P物质共价交联改性胶原基质调拌混合,置入固化模具中,然后将所述钛种植体芯的根部1以及部分冠部2插入所述固化模具中,并加压至200-300kPa,在100%湿度下固化24小时,再于-80℃冷冻12小时,真空冷冻干燥48小时。其中,所述固化模具比所述牙种植体芯的根部直径和高度分别多出3mm,从而使得所述牙种植体芯的根部1表面包被自固化磷酸钙镁-SP生物活性胶原材料,进而使得种植牙为有SP动员干细胞生物活性和模拟天然牙牙周愈合生物活性的即刻种植牙。In the 6th step, the self-curing calcium magnesium phosphate powder and the citric acid solution of 0.5mol/L are adjusted and mixed according to the mass volume concentration of 3.0g/ml to make self-curing calcium magnesium phosphate paste, and then 60%: 40% volume ratio, mix the self-curing calcium magnesium phosphate paste with the covalently cross-linked modified collagen matrix of substance P, put it into a curing mold, and then place the root of the titanium implant core 1 and part of the crown 2 are inserted into the curing mold, pressurized to 200-300kPa, cured at 100% humidity for 24 hours, then frozen at -80°C for 12 hours, and vacuum freeze-dried for 48 hours. Wherein, the curing mold is 3mm more than the root diameter and height of the dental implant core respectively, so that the surface of the root 1 of the dental implant core is coated with self-curing calcium magnesium phosphate-SP bioactive collagen material, and then The dental implant is an immediate dental implant with biological activity of SP mobilizing stem cells and biological activity of simulating natural tooth periodontal healing.
在本发明中,使用基于磷酸钙的自固化复合材料,具有良好的材料兼容性和组织相容性,用于人工牙根制备具有以下优点:易于塑形加工(包括整体材料外形、支架内部结构和支架表面形态等),可调材料强度,可控降解速率,多种功能加载(包括作为干细胞移植载体、生物因子/药物加载和缓释载体等),兼具骨引导和骨诱导活性。对于解决种植牙牙周愈合问题,具有独特优势。In the present invention, the self-curing composite material based on calcium phosphate has good material compatibility and tissue compatibility, and has the following advantages for artificial tooth root preparation: it is easy to shape and process (including the overall material shape, the internal structure of the bracket and Scaffold surface morphology, etc.), adjustable material strength, controllable degradation rate, multiple functional loading (including as stem cell transplantation carrier, biological factor/drug loading and slow release carrier, etc.), both osteoconductive and osteoinductive activities. It has unique advantages for solving the periodontal healing problems of implants.
本发明中的SP除了作为神经递质参与痛觉传导,还广泛分布于骨髓基质细胞、血管内皮细胞、中性粒细胞、上皮细胞等,发挥多种作用,被认为是一个创伤的系统反应信使,是动员干细胞和促进创伤修复的重要分子。SP还具有诱导血管新生的功能,其机制可能包括直接诱导血管内皮细胞分化和增殖,以及通过TNF-a信号等间接募集活化血管形成相关的其他细胞。SP在骨再生和骨转换(turnover,骨吸收与骨形成)活动中也有重要作用。体外研究表明SP可以刺激骨髓基质细胞(bone marrow stromal cells,or BMSCs)增殖分化并呈浓度依赖关系,药理学的研究显示,SP没有不良药理作用或遗传毒性,可以安全的用于体内细胞动员和治疗。基于以上多种特性,SP是一种方便易得、作用多样、安全可靠的小分子活性肽,具有应用于人工器官组织工程的良好作用。In addition to participating in pain transmission as a neurotransmitter, SP in the present invention is also widely distributed in bone marrow stromal cells, vascular endothelial cells, neutrophils, epithelial cells, etc., and plays a variety of roles, and is considered to be a systemic response messenger of trauma. It is an important molecule in mobilizing stem cells and promoting wound repair. SP also has the function of inducing angiogenesis, and its mechanism may include directly inducing the differentiation and proliferation of vascular endothelial cells, and indirectly recruiting and activating other cells related to angiogenesis through TNF-a signaling. SP also plays an important role in bone regeneration and bone turnover (turnover, bone resorption and bone formation). In vitro studies have shown that SP can stimulate the proliferation and differentiation of bone marrow stromal cells (bone marrow stromal cells, or BMSCs) in a concentration-dependent manner. Pharmacological studies have shown that SP has no adverse pharmacological effects or genotoxicity, and can be safely used in vivo for cell mobilization and treat. Based on the above characteristics, SP is a small molecular active peptide that is convenient and easy to obtain, has various functions, is safe and reliable, and has a good effect on artificial organ tissue engineering.
单纯SP多肽在体内会快速降解而失去活性,所以为实现SP的体内生物学效应,应设计适当的运载、定位、缓释系统以控制SP的功能作用。在本发明中,通过共价交联分子将SP连接于胶原纤维,其主要优点在于:①类似于细胞外基质,为细胞提供纳米级三维微环境,有利于细胞的黏附和生长。②胶原逐渐降解,稳定缓释SP,持续产生干细胞动员作用。③三维胶原纤维网络复合于固化的磷酸钙镁结晶之间,模拟牙根牙骨质结构,构成仿生人工牙根,并在体内以引导+诱导方式实现组织转化。Simple SP polypeptides will be rapidly degraded in vivo and lose their activity. Therefore, in order to realize the biological effects of SP in vivo, appropriate delivery, positioning, and slow-release systems should be designed to control the functional effects of SP. In the present invention, SP is connected to collagen fibers by covalent cross-linking molecules, and its main advantages are as follows: ① Similar to extracellular matrix, it provides cells with a nanoscale three-dimensional microenvironment, which is conducive to cell adhesion and growth. ②The collagen is gradually degraded, the SP is released stably and slowly, and the stem cell mobilization effect is continuously produced. ③The three-dimensional collagen fiber network is compounded between the solidified calcium and magnesium phosphate crystals, simulating the cementum structure of the tooth root, forming a bionic artificial tooth root, and realizing tissue transformation in vivo by guiding + inducing.
在本发明中,通过人工牙根生物活性物质构建自主诱导牙周愈合环境,在植入体内后能够诱导内源性牙周支持组织再生,完成人工材料向自体组织的转化改建,并最终形成稳定的牙周附着支持结构。In the present invention, the self-induced periodontal healing environment is constructed by artificial tooth root bioactive substances, which can induce the regeneration of endogenous periodontal support tissue after implantation, complete the transformation and reconstruction of artificial materials into autologous tissues, and finally form a stable Periodontal attachment support structures.
具体实施方式的内容是为了便于本领域技术人员理解和使用本发明而描述的,并不构成对本发明保护内容的限定。本领域技术人员在阅读了本发明的内容之后,可以对本发明进行合适的修改。本发明的保护内容以权利要求的内容为准。在不脱离权利要求的实质内容和保护范围的情况下,对本发明进行的各种修改、变更和替换等都在本发明的保护范围之内。The content of specific embodiments is described for the convenience of those skilled in the art to understand and use the present invention, and does not constitute a limitation to the protection content of the present invention. Those skilled in the art can make appropriate modifications to the present invention after reading the content of the present invention. The protection content of the present invention shall be determined by the content of the claims. Without departing from the essence and protection scope of the claims, various modifications, changes and replacements to the present invention are within the protection scope of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410781591.0A CN104523341B (en) | 2014-12-18 | 2014-12-18 | The manufacture method of the immediate implantation teeth with periodontal bioactivity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410781591.0A CN104523341B (en) | 2014-12-18 | 2014-12-18 | The manufacture method of the immediate implantation teeth with periodontal bioactivity |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104523341A CN104523341A (en) | 2015-04-22 |
CN104523341B true CN104523341B (en) | 2017-06-20 |
Family
ID=52839110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410781591.0A Active CN104523341B (en) | 2014-12-18 | 2014-12-18 | The manufacture method of the immediate implantation teeth with periodontal bioactivity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104523341B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107007884A (en) * | 2017-03-09 | 2017-08-04 | 温州医科大学附属口腔医院 | Carry the purposes of the pure titanium implant material of cerium oxide nano particle functional film layer |
CN116251235A (en) * | 2022-12-14 | 2023-06-13 | 中国人民解放军空军军医大学 | Porous osteoconductive/inducible self-curing calcium phosphate composite material and its preparation method |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1416913A (en) * | 2002-11-28 | 2003-05-14 | 上海瑞邦生物材料有限公司 | In-situ osteoplastic active calcium phosphate cement and its prepn and application |
CN1228083C (en) * | 2000-08-10 | 2005-11-23 | 参天制药株式会社 | Skin wound healing promoters |
CN101420922A (en) * | 2005-12-06 | 2009-04-29 | 埃特克斯公司 | Porous calcium phosphate bone material |
CN101444646A (en) * | 2007-11-27 | 2009-06-03 | 中国科学院理化技术研究所 | Composite porous microspheres of gelatin and calcium phosphate for bone repair, its preparation method and use |
CN101829357A (en) * | 2010-03-30 | 2010-09-15 | 浙江大学 | Implant surface biomimetic coating material for promoting sacralization and preparation method thereof |
CN102056619A (en) * | 2008-04-18 | 2011-05-11 | 科尔普兰特有限公司 | Methods of generating and using procollagen |
CN102145194A (en) * | 2011-04-02 | 2011-08-10 | 四川大学 | Biomedical material having porous calcium phosphate-collagen composite coating and preparation method of biomedical material |
CN103656759A (en) * | 2012-08-28 | 2014-03-26 | 医疗财团法人徐元智先生医药基金会亚东纪念医院 | composite bone cement |
CN104096264A (en) * | 2013-04-15 | 2014-10-15 | 长庚医疗科技(厦门)有限公司 | Surface-modified artificial bone material and surface modification method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011005493A2 (en) * | 2009-06-22 | 2011-01-13 | Mayo Foundation For Medical Education And Research | Methods and materials for tissue repair |
-
2014
- 2014-12-18 CN CN201410781591.0A patent/CN104523341B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1228083C (en) * | 2000-08-10 | 2005-11-23 | 参天制药株式会社 | Skin wound healing promoters |
CN1416913A (en) * | 2002-11-28 | 2003-05-14 | 上海瑞邦生物材料有限公司 | In-situ osteoplastic active calcium phosphate cement and its prepn and application |
CN101420922A (en) * | 2005-12-06 | 2009-04-29 | 埃特克斯公司 | Porous calcium phosphate bone material |
CN101444646A (en) * | 2007-11-27 | 2009-06-03 | 中国科学院理化技术研究所 | Composite porous microspheres of gelatin and calcium phosphate for bone repair, its preparation method and use |
CN102056619A (en) * | 2008-04-18 | 2011-05-11 | 科尔普兰特有限公司 | Methods of generating and using procollagen |
CN101829357A (en) * | 2010-03-30 | 2010-09-15 | 浙江大学 | Implant surface biomimetic coating material for promoting sacralization and preparation method thereof |
CN102145194A (en) * | 2011-04-02 | 2011-08-10 | 四川大学 | Biomedical material having porous calcium phosphate-collagen composite coating and preparation method of biomedical material |
CN103656759A (en) * | 2012-08-28 | 2014-03-26 | 医疗财团法人徐元智先生医药基金会亚东纪念医院 | composite bone cement |
CN104096264A (en) * | 2013-04-15 | 2014-10-15 | 长庚医疗科技(厦门)有限公司 | Surface-modified artificial bone material and surface modification method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104523341A (en) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pan et al. | Injectable hydrogel-loaded nano-hydroxyapatite that improves bone regeneration and alveolar ridge promotion | |
JPH11506659A (en) | Biocompatible hydroxyapatite formulations and uses thereof | |
Wen et al. | Biomineralization-inspired mineralized hydrogel promotes the repair and regeneration of dentin/bone hard tissue | |
Li et al. | Research progress on the biological modifications of implant materials in 3D printed intervertebral fusion cages | |
Chen et al. | Injectable calcium sulfate/mineralized collagen‐based bone repair materials with regulable self‐setting properties | |
KR20080084808A (en) | Maxillary facial bone reinforcement using rhPDGF-BB and biocompatible matrix | |
US10603410B2 (en) | Complex of implant and cultured periodontal ligament cell sheet, method for manufacturing the same, and method for using the same | |
Raja et al. | Multifunctional calcium-deficient hydroxyl apatite–alginate core–shell-structured bone substitutes as cell and drug delivery vehicles for bone tissue regeneration | |
ES2501965T3 (en) | Preparation for the regeneration of postoperative and posttraumatic bone defects | |
WO1990001341A1 (en) | Medical and dental curable material | |
JP2020508721A (en) | A method for engineering instant nanoporous bioartificial bone tissue composites | |
Xu et al. | Magnesium malate-modified calcium phosphate bone cement promotes the repair of vertebral bone defects in minipigs via regulating CGRP | |
Tang et al. | Hard tissue compatibility of natural hydroxyapatite/chitosan composite | |
CN104523341B (en) | The manufacture method of the immediate implantation teeth with periodontal bioactivity | |
Ying et al. | Shape-memory ECM-mimicking heparin-modified nanofibrous gelatin scaffold for enhanced bone regeneration in sinus augmentation | |
Wang et al. | Substance P incorporation in calcium phosphate cement for dental alveolar bone defect restoration | |
Sheikh et al. | A Novel Anabolic Conjugate (C3) in the Matrix of Dicalcium Phosphate Onlay Block Grafts for Achieving Vertical Bone Augmentation: An Experimental Study on Rabbit Calvaria. | |
JP4802317B2 (en) | Calcium phosphate ceramic bead assembly and method for constructing the same | |
CN205339653U (en) | Medical tooth planting body with surface is biological bionical | |
CN104771785B (en) | The manufacture method of the bone renovating material with nerve polypeptide induced osteogenesis activity | |
WO2017101021A1 (en) | Modified bone repairing material | |
Guarino et al. | Current Advances in Oral and Craniofacial Tissue Engineering | |
TWI414327B (en) | Complex bone cement | |
JPH04242658A (en) | Vivi-implant material and manufacture thereof | |
Sridevi et al. | Novel Dental Implants with Herbal Composites: A Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |